YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

por Rathcke Camilla, Vestergaard Henrik
Publicado 2009-01-01

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes

por Rathcke, Camilla N, Vestergaard, Henrik
Publicado 2009

YKL-40 levels are independently associated with albuminuria in type 2 diabetes

por Røndbjerg, Anne K, Omerovic, Emina, Vestergaard, Henrik
Publicado 2011

Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark

por Safai, Narges, Carstensen, Bendix, Vestergaard, Henrik, Ridderstråle, Martin
Publicado en BMJ Open (2018)

Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non‐orphan, Non‐oncology Drugs in the European Union and United States from 2012−2016

por Morant, Anne Vinther, Jagalski, Vivien, Vestergaard, Henrik Tang
Publicado en Clin Transl Sci (2019)

Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders

por Morant, Anne Vinther, Jagalski, Vivien, Vestergaard, Henrik Tang
Publicado en Front Med (Lausanne) (2019)

Increased levels of the calcification marker Matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease

por Thomsen, Stine B, Rathcke, Camilla N, Zerahn, Bo, Vestergaard, Henrik
Publicado 2010

Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and Prediction of Fatal and Non-fatal Ischemic Stroke

por Rathcke, Camilla Noelle, Thomsen, Stine Brinkloev, Linneberg, Allan, Vestergaard, Henrik
Publicado 2012

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

por Rathcke, Camilla Noelle, Persson, Frederik, Tarnow, Lise, Rossing, Peter, Vestergaard, Henrik
Publicado 2009

The Evolution of Nonclinical Regulatory Science: Advanced Therapy Medicinal Products as a Paradigm

por Vestergaard, Henrik Tang, Apote, Lucia D', Schneider, Christian K, Herberts, Carla
Publicado 2013

US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer’s Disease: Implications for Global Drug Development

por Morant, Anne Vinther, Vestergaard, Henrik Tang, Lassen, Anders Blædel, Navikas, Vaidrius
Publicado en Clin Transl Sci (2020)

NT-proBNP and Circulating Inflammation Markers in Prediction of a Normal Myocardial Scintigraphy in Patients with Symptoms of Coronary Artery Disease

por Rathcke, Camilla Noelle, Kjøller, Erik, Fogh-Andersen, Niels, Zerahn, Bo, Vestergaard, Henrik
Publicado 2010

The Association between Genetic Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and the Lipid Profile in a Danish Population

por Thomsen, Stine Brinkløv, Rathcke, Camilla Noelle, Skaaby, Tea, Linneberg, Allan, Vestergaard, Henrik
Publicado 2012

Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin

por Botha, Jaco, Nielsen, Morten Hjuler, Christensen, Maja Høegh, Vestergaard, Henrik, Handberg, Aase
Publicado en Nutr Metab (Lond) (2018)

Effects of Roux-en-Y Gastric Bypass on Fasting and Postprandial Levels of the Inflammatory Markers YKL-40 and MCP-1 in Patients with Type 2 Diabetes and Glucose Tolerant Subjects

por Thomsen, Stine Brinkløv, Rathcke, Camilla Noelle, Jørgensen, Nils Bruun, Madsbad, Sten, Vestergaard, Henrik
Publicado 2013

Variation in CHI3LI in Relation to Type 2 Diabetes and Related Quantitative Traits

por Rathcke, Camilla Noelle, Holmkvist, Johan, Jørgensen, Torben, Borch-Johnsen, Knut, Hansen, Torben, Pedersen, Oluf Borbye, Vestergaard, Henrik
Publicado 2009

Association of Polymorphisms of the CHI3L1 Gene with Asthma and Atopy: A Populations-Based Study of 6514 Danish Adults

por Rathcke, Camilla Noelle, Holmkvist, Johan, Husmoen, Lise Lotte N., Hansen, Torben, Pedersen, Oluf, Vestergaard, Henrik, Linneberg, Allan
Publicado 2009

Insulin resistance and maximal oxygen uptake

por Seibæk, Marie, Vestergaard, Henrik, Burchardt, Hans, Sloth, Carsten, Torp‐Pedersen, Christian, Nielsen, Steen Levin, Hildebrandt, Per, Pedersen, Oluf
Publicado en Clin Cardiol (2006)

Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes

por Thomsen, Stine B., Gjesing, Anette P., Rathcke, Camilla N., Ekstrøm, Claus T., Eiberg, Hans, Hansen, Torben, Pedersen, Oluf, Vestergaard, Henrik
Publicado en PLoS One (2015)

Impact of PTBP1 rs11085226 on glucose-stimulated insulin release in adult Danes

por Hansen, Tue H, Vestergaard, Henrik, Jørgensen, Torben, Jørgensen, Marit Eika, Lauritzen, Torsten, Brandslund, Ivan, Christensen, Cramer, Pedersen, Oluf, Hansen, Torben, Gjesing, Anette P
Publicado en BMC Med Genet (2015)